Scientists are currently testing different types of antivirals.
Remdesivir is one treatment that's been shown in a clinical trial to have an effect on COVID-19. Results from that trial, which included sites worldwide, found that the drug reduced patients' length of hospital stay by about four or five days. The trial did not show the drug had a significant impact on deaths.
Dexamethasone, a cheap, widely available steroid, has been shown to reduce deaths by one-third among patients on mechanical ventilators, and by one-fifth among patients receiving supplemental oxygen by other means.
The Milken Institute is curating a resource that tracks COVID-19 treatments and vaccine progress.
Updated: 20 October 2020